More importantly, the synthesized Orai1 peptide specifically targeting NCL and blocking NCL-Orai1 interaction, attenuates the growth of breast cancer cells through the reduction of NCL-meditated SOCE. This evidence concerns the gene ORAI1 and breast cancer.